A study to assess the safety, tolerability, pharmacokinetics and pharmacodynamics of AZD8233 in healthy male subjects with increased elevated LDL-C levels.

Trial Identifier: D7990C00001
Sponsor: AstraZeneca
Collaborator:
PAREXEL International
NCTID:: NCT03593785
Start Date: August 2018
Primary Completion Date: December 2020
Study Completion Date: December 2020
Condition: Hypercholesterolemia

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations